Puerarin improves graft bone defect through microRNA‑155‑3p‑mediated p53/TNF‑α/STAT1 signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Puerarin improves graft bone defect through microRNA‑155‑3p‑mediated p53/TNF‑α/STAT1 signaling pathway

Published:2020-05-06 Issue:1 Volume:46 Page:239-251
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Zhou Yang¹,Lian Hongyu²,Liu Kexin²,Wang Deli³,Xiu Xuelian¹,Sun Zhang¹

Affiliation:

1. Department of Stomatology, Mudanjiang Medical University, Affiliated Hongqi Hospital, Mudanjiang, Heilongjiang 157000, P.R. China

2. Second Department of Orthopedics Surgery, Mudanjiang Medical University, Affiliated Hongqi Hospital, Mudanjiang, Heilongjiang 157000, P.R. China

3. Department of Stomatology, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157000, P.R. China

Publisher

Spandidos Publications

Subject

Genetics,General Medicine

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Puerarin suppresses macrophage M1 polarization to alleviate renal inflammatory injury through antagonizing TLR4/MyD88-mediated NF-κB p65 and JNK/FoxO1 activation;Phytomedicine;2024-09

2. [Retracted] Puerarin improves graft bone defect through microRNA‑155‑3p‑mediated p53/TNF‑α/STAT1 signaling pathway;International Journal of Molecular Medicine;2024-07-22

3. Comprehensive assessment of circulatory miRNAs as potential diagnostic markers in HCV recurrence post liver transplantation;Diagnostic Microbiology and Infectious Disease;2024-07

4. Unraveling the pharmacodynamic substances and possible mechanism of Trichosanthis Pericarpium in the treatment of coronary heart disease based on plasma pharmacochemistry, network pharmacology and experimental validation;Journal of Ethnopharmacology;2024-05

5. Puerarin mediated miR-30b-5p targeting fibroblast activation protein against oral submucous fibrosis;BIOCELL;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3